AXIL Brands Reports Q3 2025 Financial Results Amid Restructuring and Growth Efforts

AXIL Brands, Inc. (PINK: RVIV) Overview

AXIL Brands, Inc., formerly known as Reviv3 Procare Company, has reported its financial results for the three and nine months ended February 28, 2025. Key highlights reveal changes in sales, operating expenses, and net income, reflecting the company's ongoing restructuring and growth strategies in the hearing and skin care market.

Key Financial Highlights

• Net Sales: - Q3 2025: $6,922,367 (up 7.0% from $6,469,343 in Q3 2024) - YTD 2025: $20,506,213 (down 2.3% from $20,997,289 in YTD 2024)
• Cost of Sales: - Q3 2025: $1,955,939 (up 6.0% from $1,845,017 in Q3 2024) - YTD 2025: $5,888,090 (up 7.7% from $5,467,458 in YTD 2024)
• Gross Profit: - Q3 2025: $4,966,428 (margin of 71.7%) - YTD 2025: $14,618,123 (margin of 71.3%)
• Operating Expenses: - Q3 2025: $4,383,319 (down 7.3% from $4,728,205 in Q3 2024) - YTD 2025: $13,502,845 (down 4.9% from $14,196,041 in YTD 2024)
• Net Income: - Q3 2025: $576,662 (down from $781,091 in Q3 2024) - YTD 2025: $1,100,563 (down from $1,953,618 in YTD 2024)
• Adjusted EBITDA: - Q3 2025: $890,546 - YTD 2025: $2,076,821

Positive Aspects:

• Increased net sales growth for Q3 indicates effective marketing strategies, particularly in direct-to-consumer channels.
• Operational expense reduction demonstrates improved cost control measures, notably in advertising.
• Positive cash flow from operations of $1,734,230 for YTD 2025, showcasing a significant improvement over last year.

Negative Aspects:

• YTD sales decline raises concerns about sustained revenue growth amid fluctuating marketing strategies.
• Increased cost of sales impacts gross margins, revealing vulnerability in pricing strategy and product costs.
• Net income has substantially decreased compared to the previous year, reflecting challenges in maintaining profitability.

Outlook

AXIL is currently shifting its supply chain strategies through U.S.-based manufacturing initiatives to enhance operational flexibility in response to trade policies. While the increased costs due to tariffs are expected in the short-term, management remains confident in its strategic growth plans, aiming to bolster its market presence in both domestic and international markets.